trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Liver Cirrhosis D008103 67 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Stroke D020521 32 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Lim SY et al. Enhancing Human Cardiomyocyte Differentiation from Induced Pluripotent Stem Cells with Trichostatin A. 2016 Methods Mol. Biol. pmid:25520285
Contreras-Leal E et al. Histone deacetylase inhibitors promote the expression of ATP2A3 gene in breast cancer cell lines. 2016 Mol. Carcinog. pmid:26331238
Tombolan L et al. Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma. 2016 BMC Cancer pmid:27842508
Tao W et al. Histone deacetylase inhibitor-induced emergence of synaptic δ-opioid receptors and behavioral antinociception in persistent neuropathic pain. 2016 Neuroscience pmid:27646288
Chen W et al. MicroRNA-455-3p modulates cartilage development and degeneration through modification of histone H3 acetylation. 2016 Biochim. Biophys. Acta pmid:27638301
Bauer I et al. A Class 1 Histone Deacetylase with Potential as an Antifungal Target. 2016 MBio pmid:27803184
Igaz N et al. Modulating chromatin structure and DNA accessibility by deacetylase inhibition enhances the anti-cancer activity of silver nanoparticles. 2016 Colloids Surf B Biointerfaces pmid:27434153
Qu H et al. Trichostatin A increases the TIMP-1/MMP ratio to protect against osteoarthritis in an animal model of the disease. 2016 Mol Med Rep pmid:27431944
Choi SY et al. Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells. 2016 J. Cell. Mol. Med. pmid:27420561
Dhoke NR et al. Histone deacetylases differentially regulate the proliferative phenotype of mouse bone marrow stromal and hematopoietic stem/progenitor cells. 2016 Stem Cell Res pmid:27394013
Drzewiecka H et al. Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers. 2016 J. Cancer Res. Clin. Oncol. pmid:27393180
Ma X et al. Identification of genes regulated by histone acetylation during root development in Populus trichocarpa. 2016 BMC Genomics pmid:26847576
Li L et al. Trichostatin A potentiates TRAIL-induced antitumor effects via inhibition of ERK/FOXM1 pathway in gastric cancer. 2016 Tumour Biol. pmid:26831669
Rios EC et al. The role of nitric oxide in the epigenetic regulation of THP-1 induced by lipopolysaccharide. 2016 Life Sci. pmid:26826317
Wang X et al. The synergistic effect of 5Azadc and TSA on maintenance of pluripotency of chicken ESCs by overexpression of NANOG gene. 2016 In Vitro Cell. Dev. Biol. Anim. pmid:26822431
Saini M et al. Treatment of buffalo (Bubalus bubalis) donor cells with trichostatin A and 5-aza-2'-deoxycytidine alters their growth characteristics, gene expression and epigenetic status and improves the in vitro developmental competence, quality and epigenetic status of cloned embryos. 2016 Reprod. Fertil. Dev. pmid:25409339
Kim HJ et al. Enhancement of human mesenchymal stem cell differentiation by combination treatment with 5-azacytidine and trichostatin A. 2016 Biotechnol. Lett. pmid:26341652
Iancu-Rubin C and Hoffman R Role of epigenetic reprogramming in hematopoietic stem cell function. 2015 Curr. Opin. Hematol. pmid:26049747
Huisman C et al. Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs. 2015 Epigenetics pmid:25830725
Fujii K et al. Lactogenic hormone stimulation and epigenetic control of L-amino acid oxidase expression in lactating mammary glands. 2015 J. Cell. Physiol. pmid:25820447
Pandey SC et al. Potential role of adolescent alcohol exposure-induced amygdaloid histone modifications in anxiety and alcohol intake during adulthood. 2015 Neurobiol. Dis. pmid:25814047
Chan N et al. Attenuation of choroidal neovascularization by histone deacetylase inhibitor. 2015 PLoS ONE pmid:25807249
Asaoka N et al. Inhibition of histone deacetylases enhances the function of serotoninergic neurons in organotypic raphe slice cultures. 2015 Neurosci. Lett. pmid:25796177
Butler PL et al. Acetylation stimulates the epithelial sodium channel by reducing its ubiquitination and degradation. 2015 J. Biol. Chem. pmid:25787079
Hartman H et al. Histone deacetylase regulates trypsin activation, inflammation, and tissue damage in acute pancreatitis in mice. 2015 Dig. Dis. Sci. pmid:25492506
Jiang H et al. Changes of spontaneous parthenogenetic activation and development potential of golden hamster oocytes during the aging process. 2015 Acta Histochem. pmid:25480399
Du J et al. HDAC4 degradation mediates HDAC inhibition-induced protective effects against hypoxia/reoxygenation injury. 2015 J. Cell. Physiol. pmid:25475100
Xu T and Hu X Copper-catalyzed 1,2-addition of α-carbonyl iodides to alkynes. 2015 Angew. Chem. Int. Ed. Engl. pmid:25470461
Rabineau M et al. Cell guidance into quiescent state through chromatin remodeling induced by elastic modulus of substrate. 2015 Biomaterials pmid:25453945
Cui Y et al. Interference of the Histone Deacetylase Inhibits Pollen Germination and Pollen Tube Growth in Picea wilsonii Mast. 2015 PLoS ONE pmid:26710276
Fukui T et al. Histone deacetylase inhibitor attenuates neurotoxicity of clioquinol in PC12 cells. 2015 Toxicology pmid:25758465
Wang Y et al. Identification of histone deacetylase inhibitors with benzoylhydrazide scaffold that selectively inhibit class I histone deacetylases. 2015 Chem. Biol. pmid:25699604
Chahine MN et al. Nuclear pore rearrangements and nuclear trafficking in cardiomyocytes from rat and human failing hearts. 2015 Cardiovasc. Res. pmid:25341891
Ji M et al. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells. 2015 Oncol. Rep. pmid:25813246
Tao Y et al. HDAC1 regulates the proliferation of radial glial cells in the developing Xenopus tectum. 2015 PLoS ONE pmid:25789466
Wang Y et al. Inhibition of histone deacetylase in the basolateral amygdala facilitates morphine context-associated memory formation in rats. 2015 J. Mol. Neurosci. pmid:24829091
Li Z et al. DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer. 2015 Gastric Cancer pmid:24481854
Rodrigues MF et al. Reciprocal modulation of histone deacetylase inhibitors sodium butyrate and trichostatin A on the energy metabolism of breast cancer cells. 2015 J. Cell. Biochem. pmid:25510910
Uchida H et al. Histone deacetylase inhibitors relieve morphine resistance in neuropathic pain after peripheral nerve injury. 2015 J. Pharmacol. Sci. pmid:26318673
Zhang P et al. Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling. 2015 PLoS ONE pmid:26287365
Perez-Janices N et al. Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis. 2015 Oncotarget pmid:26284587
Keil KP et al. Histone acetylation regulates prostate ductal morphogenesis through a bone morphogenetic protein-dependent mechanism. 2015 Dev. Dyn. pmid:26283270
Hsing CH et al. Histone Deacetylase Inhibitor Trichostatin A Ameliorated Endotoxin-Induced Neuroinflammation and Cognitive Dysfunction. 2015 Mediators Inflamm. pmid:26273133
Zhou L et al. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis. 2015 J. Virol. pmid:26269170
Huan Y et al. Epigenetic Modification Agents Improve Gene-Specific Methylation Reprogramming in Porcine Cloned Embryos. 2015 PLoS ONE pmid:26068219
Huan Y et al. Epigenetic Modification of Cloned Embryos Improves Nanog Reprogramming in Pigs. 2015 Cell Reprogram pmid:26053519
Kaldre D et al. Optimization of histone deacetylase inhibitor activity in non-secosteroidal vitamin D-receptor agonist hybrids. 2015 Bioorg. Med. Chem. pmid:26048026
Liu Y and Li S A Cell Culture Model of Latent and Lytic Herpes Simplex Virus Type 1 Infection in Spiral Ganglion. 2015 ORL J. Otorhinolaryngol. Relat. Spec. pmid:26022499
Jost JO et al. A miniaturized readout strategy for endogenous histone deacetylase activity. 2015 Mol Biosyst pmid:26009008
Koppaka V et al. Effect of HDAC Inhibitors on Corneal Keratocyte Mechanical Phenotypes in 3-D Collagen Matrices. 2015 Mol. Vis. pmid:25999677